Author | Evan Y. Yu, MD | OncLive

Author | Evan Y. Yu, MD

Articles

Dr. Yu on Future Directions in Prostate Cancer

July 25, 2019

Video

Evan Y. Yu, MD, professor, Department of Medical Oncology, University of Washington School of Medicine, member, Clinical Research Division, Fred Hutchinson Cancer Research Center, and clinical trials core director, Genitourinary Medical Oncology, Seattle Cancer Care Alliance, discusses future directions in prostate cancer.

Dr. Yu on Initial Findings From the KEYNOTE-365 Trial in mCRPC

July 19, 2019

Video

Evan Y. Yu, MD, professor, Department of Medical Oncology, University of Washington School of Medicine, member, Clinical Research Division, Fred Hutchinson Cancer Research Center, and clinical trials core director, Genitourinary Medical Oncology, Seattle Cancer Care Alliance, discusses initial findings from the KEYNOTE-365 trial in metastatic castration resistant prostate cancer mCRPC).

Dr. Yu on Rationale for the KEYNOTE-365 Study in mCRPC

July 09, 2019

Video

Evan Y. Yu, MD, discusses the rationale behind the KEYNOTE-365 trial, looking at pembrolizumab plus olaparib in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel.

Dr. Yu on Combining Pembrolizumab and Olaparib in mCRPC

June 21, 2019

Video

Evan Y. Yu, MD, professor, Department of Medicine, Division of Oncology, University of Washington, Seattle Cancer Care Alliance, discusses combining pembrolizumab and olaparib in metastatic castration-resistant prostate cancer.

x